Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100893Source: DataRank Database

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice is a research paper published in Cell Reports Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 3.68)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Guillaume Beaudoin-Bussières ORCID,Kelly Symmes ORCID,Marc Cloutier ORCID,Éric Ducas,Alexandra Tauzin ORCID

Live enrichment

PubMed:36584683 PMC:PMC9799175 OpenAlex:https://openalex.org/W4313333208

Canadian Institutes of Health Research

Grant: 177958

Canadian Institutes of Health Research

Grant: 352417

National Institutes of Health

Grant: R01AI163395

Canada Foundation for Innovation

Grant: 41027

National Institute of Allergy and Infectious Diseases

Grant: T32AI055403

Fondation du CHU de Quebec

Grant: 281662

Fondation du CHUM

Cummings Foundation

Fonds de Recherche du Québec - Santé

FWCI

3.68

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xcrm.2022.100893

publisherhttps://doi.org/10.1016/j.xcrm.2022.100893

publisherhttps://api.elsevier.com/content/article/PII:S2666379122004724?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666379122004724?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36584683

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComplement system in diseasesAnimalsMiceSARS-CoV-2COVID-19COVID-19 SerotherapyTreatment OutcomeImmunoglobulin G

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAnimalsImmunoglobulin GTreatment OutcomeMice

Keywords

Convalescent plasmaNeutralizationNeutralizing antibodyEffectorAntibodyImmunologyCoronavirus disease 2019 (COVID-19)TiterVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineImmunityIn vivoImmune systemBiologyInternal medicineDiseaseInfectious disease (medical specialty)MacrophagesNeutrophilsIgGIgMADCCIGACovid-19Sars-cov-2Fc-effector

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (2)

Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey

N/A

0.718DataRank · unranked

Transfusion(2021)

co-cited

10.1111/trf.16449

Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years

N/A

1.2DataRank · unranked

New England Journal of Medicine(2023)

co-cited

10.1056/nejmoa2202348

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice

FAIR Checklist

Authors (16)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)